239 related articles for article (PubMed ID: 29998368)
1. Serum BAFF and APRIL levels in Indian patients with Takayasu arteritis.
Zanwar A; Jain A; Gupta L; Chaurasia S; Kumar S; Misra DP; Misra R
Clin Rheumatol; 2018 Dec; 37(12):3439-3442. PubMed ID: 29998368
[TBL] [Abstract][Full Text] [Related]
2. Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease.
Xin G; Cui Z; Su Y; Xu LX; Zhao MH; Li KS
Nephrology (Carlton); 2013 Mar; 18(3):209-14. PubMed ID: 23317407
[TBL] [Abstract][Full Text] [Related]
3. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
Eilertsen GØ; Nossent JC
Lupus; 2014 Nov; 23(13):1383-91. PubMed ID: 25057039
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of BAFF for assessing the disease activity of Takayasu arteritis.
Nishino Y; Tamai M; Kawakami A; Koga T; Makiyama J; Maeda Y; Jiuchi Y; Miyashita T; Izumi Y; Eguchi K; Migita K
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):14-7. PubMed ID: 20412696
[TBL] [Abstract][Full Text] [Related]
5. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
6. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
[TBL] [Abstract][Full Text] [Related]
7. High APRIL but not BAFF serum levels are associated with poor outcome in patients with follicular lymphoma.
Li YJ; Li ZM; Xia ZJ; Li S; Xia Y; Huang HQ; Huang JJ; Yi PY; Jiang WQ
Ann Hematol; 2015 Jan; 94(1):79-88. PubMed ID: 25146008
[TBL] [Abstract][Full Text] [Related]
8. Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis.
Kobayashi N; Kobayashi I; Mori M; Sato S; Iwata N; Shigemura T; Agematsu K; Yokota S; Koike K
J Rheumatol; 2015 Dec; 42(12):2412-8. PubMed ID: 26472413
[TBL] [Abstract][Full Text] [Related]
9. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity.
Nagai M; Hirayama K; Ebihara I; Shimohata H; Kobayashi M; Koyama A
Nephron Clin Pract; 2011; 118(4):c339-45. PubMed ID: 21293157
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
[TBL] [Abstract][Full Text] [Related]
12. Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey.
Karabacak M; Kaymaz-Tahra S; Şahin S; Yıldız M; Adroviç A; Barut K; Direskeneli H; Kasapçopur Ö; Alibaz-Öner F
Semin Arthritis Rheum; 2021 Feb; 51(1):192-197. PubMed ID: 33383295
[TBL] [Abstract][Full Text] [Related]
13. Serum BAFF and APRIL levels in patients with PBC.
Migita K; Ilyassova B; Kovzel EF; Nersesov A; Abiru S; Maeda Y; Komori A; Ito M; Yano K; Yatsuhashi H; Shimoda S; Ishibashi H; Nakamura M
Clin Immunol; 2010 Feb; 134(2):217-25. PubMed ID: 19840904
[TBL] [Abstract][Full Text] [Related]
14. Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis.
Phatak S; Chaurasia S; Mishra SK; Gupta R; Agrawal V; Aggarwal A; Misra R
Clin Exp Immunol; 2017 Mar; 187(3):376-382. PubMed ID: 27804111
[TBL] [Abstract][Full Text] [Related]
15. BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Colliver JA; Ness JM; Ransohoff RM
J Neuroinflammation; 2013 Jan; 10():10. PubMed ID: 23324534
[TBL] [Abstract][Full Text] [Related]
16. Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: relation to clinical manifestations and disease activity.
Gheita TA; Bassyouni IH; Emad Y; el-Din AM; Abdel-Rasheed E; Hussein H
Joint Bone Spine; 2012 May; 79(3):285-90. PubMed ID: 21733733
[TBL] [Abstract][Full Text] [Related]
17. Serum BAFF and APRIL levels in patients with autoimmune hemolytic anemia and their clinical significance.
Xu ZZ; Zhao BB; Xiong H; Wei BW; Wang YF
Int J Hematol; 2015 Oct; 102(4):394-400. PubMed ID: 26243624
[TBL] [Abstract][Full Text] [Related]
18. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
Sahin S; Hopurcuoglu D; Bektas S; Belhan E; Adrovic A; Barut K; Canpolat N; Caliskan S; Sever L; Kasapcopur O
Int J Rheum Dis; 2019 Jan; 22(1):132-139. PubMed ID: 30397997
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of ligands belonging to tumour necrosis factor superfamily in acute lymphoblastic leukaemia.
Bolkun L; Lemancewicz D; Jablonska E; Szumowska A; Bolkun-Skornicka U; Moniuszko M; Dzieciol J; Kloczko J
Leuk Res; 2015 Mar; 39(3):290-5. PubMed ID: 25582383
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum 25-hydroxyvitamin D: a potential indicator of remission in Takayasu arteritis patients with normal ESR and CRP levels.
Liao H; Du J; Li F; Yang S; Qi G; Pan L
Clin Rheumatol; 2024 Jun; 43(6):1979-1987. PubMed ID: 38598024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
